Did you know?

Total Valuation. ABCL has a market cap or net worth of $1.37 billion. The enterprise value is $630.32 million. Market Cap. 1.37B. Enterprise Value. 630.32M.About the AbCellera Biologics Inc stock forecast. As of 2023 November 28, Tuesday current price of ABCL stock is 4.530$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).See the latest AbCellera Biologics Inc Ordinary Shares stock price (ABCL:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.A high-level overview of AbCellera Biologics Inc. (ABCL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. AbCellera Biologics Inc (ABCL). 4.34 -0.26 (-5.65%) USD ... Price to book value is a valuation ratio that is measured by stock price / book value per share.Aditya Birla Sun Life AMC Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 12,911.38 Crore) operating in Financial Services sector. Aditya Birla Sun Life AMC Ltd. key Products/Revenue Segments include Fees & Commission Income for the year ending 31-Mar-2023.For ...1 Month Ago. -$0.12. 3 Months Ago. -$0.14. AbCellera Biologics Inc. analyst estimates, including ABCL earnings per share estimates and analyst recommendations. For Abcam plc stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Abcam plc stock forecast of 1878.0, a high forecast of 2240.87, and a low forecast of 1688.28. The average Abcam plc stock forecast 2026 represents a 53.18% increase from the last price of 1226.0.May 26, 2023 · ABCL Stock Performance: A Look at May 26, 2023. On May 26, 2023, Abcellera Biologics Inc (ABCL) saw a significant increase in its stock price, with shares trading at $28.00, up 306.39% from the previous day’s closing price. This surge in price can be attributed to the positive outlook of the 9 analysts who offer 12-month price forecasts for ABCL. Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.AbCellera Biologics (ABCL) Risk Factors. Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F).According to our current ABC stock forecast, the value of AmerisourceBergen shares will rise by 0.00% and reach $ 179.98 per share by November 22, 2023. According to our technical indicators, the current …52-Week Range $3.87 - $14.97. Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K.View live AbCellera Biologics Inc. chart to track its stock's price ... View live AbCellera Biologics Inc. chart to track its stock's price action. Find market predictions, ABCL financials and market ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . ABCL chart. Today 1.06% 5 ...Previous Close $4.4. Volume 1.91M. Average Volume (3M) 1.64M. Market Cap. $1.28B. Enterprise Value $1.28B. Total Cash (Recent Filing) $795.69K. Total Debt (Recent Filing) $84.03K. Price to Earnings (P/E) -9.8. According to analyst projections, ABCL’s forecast low is $10.00 with $34.00 as the target high. To hit the forecast high, the stock’s price needs a -639.13% plunge from its current level, while the stock would need to soar -117.39% for it to hit the projected low. AbCellera Biologics Inc (ABCL) estimates and forecastsVANCOUVER, British Columbia, November 03, 2023--AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023. Find the latest AbCellera Biologics Inc. (ABCL) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest AbCellera Biologics Inc. ABCL analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.Nov 21, 2023 · According to analyst projectioPenny stocks may sound like an interesting investment option, b This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $20.00 ,the lowest forecast is $10.00. The average price target represents 238.60% Increase from the current price of $4.43.Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. AbCellera Biologics stock news, updates & related news. Find out why AbCellera Biologics's (ABCL) news sentiment is 14.35% more negative in relation to stocks in the Healthcare sector. According to data from CNN Money, the 8 analysts Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...Vortex Energy Corp () Stock Market info Recommendations: Buy or sell Vertex Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Vertex Pharmaceuticals's VRTX shares and … AbCellera Biologics saw a drop in short interest in the month of No

Abcellera Biologics Inc. 4.76. Delayed Data. As of 3:59pm ET. +0.035 / +0.74%. Today’s Change. 3.87. Today ||| 52-Week Range. 14.00.AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.54 per share a year ago.Get the latest information on AbCellera Biologics Inc. (ABCL), a biotechnology company that discovers antibodies from natural immune responses. See its stock price, earnings, revenue, financial statements, analyst forecasts, news and more.

With its Q4 2022 results that exceeded revenue consensus but lagged earnings expectations, LLY raised its adj. EPS forecast to $8.35 - $8.55 and kept its 2023 revenue guidance unchanged at $30.3B ...5 abr 2023 ... Their average price target stands at $19, implying 266% upside potential. AbCellera Biologics (ABCL). Pipette adding fluid to one of several ...Analyst projections state that ABCL is forecast to be at a low of $10.00 and a high of $34.00. In order for the stock price to hit the forecast high, the stock would need to plunge -660.63% from its current level, while the stock would need to crash -123.71% from its current level to reach the projected low.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. 2,065.00 -2.10(-0.10%) AbCellera Biologics . Possible cause: Walt Disney Co. (NYSE: DIS) had a rough pandemic lockdown period.Parks closed for over.